This inventor holds 3 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignee: Allergan, Inc.. Active years: 2018-2021.
Location History:
- Irvine, CA (US) (2018 - 2019)
- Costa Mesa, CA (US) (2021)
Company Filing History:
Years Active: 2018-2021
Title: Christopher D Hein: Innovator in Pharmaceutical Compounds
Introduction
Christopher D Hein is a notable inventor based in Irvine, CA. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that address inflammatory and autoimmune diseases. With a total of 3 patents to his name, Hein's work is recognized for its potential therapeutic applications.
Latest Patents
Hein's latest patents include innovative compounds such as "3,4-disubstituted 3-cyclobutene-1,2-diones and use thereof." These compounds are described as pharmaceutically acceptable salts that are useful for treating various inflammatory and autoimmune diseases. Another significant patent involves "EPagonists as therapeutic compounds," which details compounds that act as EPagonists and antagonists, targeting a range of pathological conditions associated with EPreceptors.
Career Highlights
Hein is currently employed at Allergan, Inc., where he continues to advance his research and development efforts. His work at Allergan has positioned him as a key player in the pharmaceutical industry, contributing to the creation of innovative treatments.
Collaborations
Hein has collaborated with esteemed colleagues such as David W Old and Tien T Duong. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
Christopher D Hein is a prominent inventor whose work in pharmaceutical compounds has the potential to significantly impact the treatment of inflammatory and autoimmune diseases. His contributions to the field are noteworthy and continue to inspire innovation in pharmaceutical research.